Our Goal Is To Be A Pioneer In Biological Medicines!
Led by the Gamaleya Epidemiology and Microbiology Research Center, which has over 40 years of experience in adenoviral vectors, production processes of the first adenovector-based COVID-19 vaccine were initiated in Turkey.
In the field of biotechnology, by establishing business partnerships in international markets for Viscoran-identified innovative products, we carry out post-technology transfer production, sales-marketing, import and export activities.
COVID-19 vaccine based on human Adenovirus vectors, pioneered by Viscoran in Turkey; It is a platform developed by the Russian Gamaleya Epidemiology and Microbiology Research Center and has been studied since the 1980s.
Biotechnology is a multidisciplinary branch of science and technology that uses living organisms or systems to obtain useful products, improving the quality of human life and furthering product development as a result of the interactions between biological sciences and technology, such as biology, biochemistry, microbiology.